U.S. Electrical Stock News

NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

A Look At Palomar Holdings (PLMR) Valuation After Recent Share Price Weakness

Recent share performance and business snapshot Palomar Holdings (PLMR) has seen its stock decline about 15% over the past month and about 16% over the past 3 months, drawing investor attention to how this specialty insurer is currently valued. The company focuses on property and casualty insurance in the United States, with about US$980.3m in revenue and US$197.1m in net income, and a market cap near US$2.9b based on its recent close at US$110.78. See our latest analysis for Palomar...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

A Look At Apellis Pharmaceuticals (APLS) Valuation After The Biogen Acquisition Announcement

Why Apellis Pharmaceuticals (APLS) Is On Investors’ Radar Apellis Pharmaceuticals (APLS) has drawn fresh attention after being acquired by Biogen, with the company now operating as a subsidiary as of May 14, 2026, while its stock continues to trade independently. See our latest analysis for Apellis Pharmaceuticals. At a share price of US$41.03, Apellis has seen a sharp 90 day share price return of 89.08% and a 1 year total shareholder return of 135.13%. However, the 3 year total shareholder...
NasdaqGM:SEPN
NasdaqGM:SEPNPharmaceuticals

Assessing Septerna (SEPN) Valuation After Strong Q1 Results And Progress Toward Breakeven

Septerna (SEPN) drew fresh attention after first quarter 2026 results showed sales of US$26.52 million and a narrower net loss of US$8.64 million. Analysts view these developments as progress toward breakeven. See our latest analysis for Septerna. The stock has been volatile around these results, with a 1-day share price return showing a 4.84% decline after the earnings release, a 7-day share price return showing a 12.90% gain, and a 1-year total shareholder return of about 1.7x, which points...
NYSE:TSN
NYSE:TSNFood

Tyson Foods Pork Settlement Puts Regulatory Risks And Valuation In Focus

Tyson Foods (NYSE:TSN) has agreed to a US$48 million antitrust class action settlement tied to price-fixing and market allocation allegations in the U.S. pork supply chain. The settlement includes both cash payments and non-monetary relief to resolve long-running claims related to pork pricing practices. This development highlights ongoing legal and regulatory scrutiny of pricing conduct across the broader meat and protein sector. Tyson Foods is a major U.S. meat producer with significant...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

Nano Nuclear’s NRC Filing Puts KRONOS MMR Progress In Sharper Focus

Nano Nuclear Energy (NasdaqCM:NNE) has submitted a Construction Permit Application to the U.S. Nuclear Regulatory Commission for its KRONOS MMR microreactor system. The proposed project is located at the University of Illinois, tying the microreactor to an academic and research setting. This filing marks a key regulatory and commercialization milestone for the KRONOS MMR that has not been highlighted in earlier coverage. Nano Nuclear Energy focuses on developing microreactor systems, with...
NYSE:TEX
NYSE:TEXMachinery

Terex (TEX) Valuation Check After Analyst Upgrade And Environmental Solutions And REV Group Expansion

Terex (TEX) moved into focus after an analyst upgrade related to its acquisitions in Environmental Solutions Group and REV Group, as well as firm demand in aerials, prompting fresh questions about how the stock is currently priced. See our latest analysis for Terex. Even after the analyst upgrade and acquisitions news, Terex’s share price has been choppy, with a 1-day share price return down 5.9% and a 90-day share price return down 13.14%. However, its 1-year total shareholder return of...
NYSE:ADC
NYSE:ADCRetail REITs

A Look At Agree Realty (ADC) Valuation After Recent Share Price Weakness

Recent share performance puts Agree Realty in focus Agree Realty (ADC) has drawn fresh attention after a period where the stock has slipped around 4% over the past month and past 3 months, despite reporting revenue of US$750.045m and net income of US$211.53m. See our latest analysis for Agree Realty. That short-term weakness extends a pattern of softer momentum, with the share price down 4.6% over the past 3 months, while the year-to-date share price return is 3.2% and the 5-year total...
NYSE:JOBY
NYSE:JOBYAirlines

Did Joby’s Liquidity Boost and 2026 eVTOL Timeline Just Shift Joby Aviation's (JOBY) Investment Narrative?

Joby Aviation, Inc. reported past first-quarter 2026 results with sales of US$24.25 million and a net loss of US$109.95 million, while reaffirming plans to begin commercial eVTOL air taxi operations in 2026 under the White House’s eVTOL Integration Pilot Program. Recent point-to-point demonstration flights between JFK Airport and Manhattan, alongside Joby’s build-out of vertiports and charging infrastructure, highlight how the company is already testing key elements of its proposed urban air...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line (NCLH) Is Down 9.1% After Lowering Full-Year EPS Guidance and Facing Legal Probe – What's Changed

Norwegian Cruise Line Holdings recently reported first-quarter 2026 results showing revenue of US$2,331.22 million and net income of US$104.67 million, while also facing shareholder activism over board declassification, a securities law investigation tied to lowered full-year EPS guidance, and new ESOP-related share registration. At the same time, the company is attracting fresh attention from both institutional investors and its own directors through sizeable share purchases, even as it...
NasdaqCM:KARO
NasdaqCM:KAROSoftware

Karooooo (NasdaqCM:KARO) Valuation Check After 19% Subscription Growth And Higher Dividend

Karooooo (KARO) caught investor attention after reporting 19% subscription revenue growth for FY 2026, an increased dividend, and new FY 2027 guidance focused on expansion, new products, and earnings per share. See our latest analysis for Karooooo. Karooooo's recent dividend hike and FY 2027 outlook landed after a softer period for the stock, with the 30-day share price return down 11.5% and the 1-year total shareholder return down 13.2%, even though the 3-year total shareholder return is...
NasdaqGS:OLMA
NasdaqGS:OLMABiotechs

Olema Pharmaceuticals (OLMA) Deepens Trial Spend With Ample Cash Buffer Is Its Risk-Reward Now Clearer?

Olema Pharmaceuticals reported past first-quarter 2026 results, with a US$53.09 million net loss and basic loss per share of US$0.52, driven by higher spending on late-stage breast cancer trials and early-stage pipeline work. Despite the larger loss, the company ended the quarter with a strong US$505.3 million cash balance and outlined key upcoming milestones, including pivotal Phase 3 palazestrant data and initial OP-3136 results at ASCO 2026. Against this backdrop, we’ll explore how...
NYSE:APH
NYSE:APHElectronic

Amphenol Joins EBO Standard To Shape AI Data Center Connectivity

Amphenol (NYSE:APH) has joined a new multi source agreement to standardize expanded beam optical connectivity for AI data centers. The group includes 3M, AMD, Cisco, Meta and Arista Networks, collaborating on open, interoperable EBO specifications. The initiative targets next generation data center infrastructure used by hyperscale and enterprise customers. Amphenol is a large connector and interconnect systems supplier, with products that feed into data centers, communications, automotive...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

How AI-Fueled Beat, Dividend Hike and Stock Split At KLA (KLAC) Has Changed Its Investment Story

KLA Corporation recently reported fiscal third-quarter results that exceeded its own guidance, confirmed a strong 2026 outlook tied to AI chip demand, raised its quarterly dividend to US$2.30 per share, and announced a 10‑for‑1 forward stock split effective after trading on June 11, 2026. The combination of continued AI-driven demand, higher cash returns via dividends and buybacks, and a pending stock split highlights management’s confidence in KLA’s core process-control franchise and its...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

How Investors May Respond To Oruka Therapeutics (ORKA) Psoriasis Data And Upsized US$700 Million Offering

Oruka Therapeutics, Inc. recently reported a first-quarter 2026 net loss of US$31.82 million, wider than a year earlier, while releasing encouraging interim psoriasis data showing very high complete skin clearance rates for its lead candidate ORKA-001 and advancing ORKA-002 into Phase 2 trials. The company also completed an upsized US$700 million public offering and expanded development plans, underscoring both its capital access and its ambition to build a broader portfolio in...
NasdaqGS:AVAV
NasdaqGS:AVAVAerospace & Defense

Could AeroVironment’s (AVAV) PANTHER Deal Quietly Redefine Its Role In Advanced Defense Infrastructure?

In May 2026, the Department of War Test Resource Management Center awarded AeroVironment a three-year, US$43 million contract to integrate its PANTHER phased-array antenna system onto SkyRange high-altitude unmanned platforms, upgrading U.S. missile and hypersonic weapons testing infrastructure with mobile, multi-target tracking capability. Beyond the contract size, the program extends AeroVironment’s role from unmanned aircraft into test-range infrastructure and workforce development,...
NYSE:GEL
NYSE:GELOil and Gas

A Look At Genesis Energy (GEL) Valuation After Its First Quarter Turnaround And Optimistic Outlook

Genesis Energy (GEL) is back in focus after first quarter earnings, as revenue reached US$446.56 million and the company reported net income of US$6.8 million compared with a loss a year earlier. See our latest analysis for Genesis Energy. Recent trading has been softer, with a 30 day share price return of down 6.78% and a 90 day share price return of down 8.27%. However, the 1 year total shareholder return of 9.31% and 5 year total shareholder return of 112.47% show longer term holders have...
NYSE:FLR
NYSE:FLRConstruction

What Fluor (FLR)'s Earnings Rebound, Woodsmith Win and Buybacks Strategy Means For Shareholders

Fluor Corporation recently reported past first-quarter 2026 results showing sales of US$3,663 million, a return to net income of US$160 million, and continued share repurchases under its long-running buyback program, while also being selected by Anglo American to perform feasibility study services for the Woodsmith mining project in England. Beyond the headline earnings recovery, the combination of large-scale nuclear and mining work with substantial share repurchases highlights how Fluor is...
NasdaqGS:FWON.K
NasdaqGS:FWON.KEntertainment

Is Formula One Group (FWON.K) Pricing Reflect Its Slowing Share Gains And Premium P/E?

Wondering if Formula One Group at around US$89.54 is priced fairly or if the market is missing something? This article looks at what the current valuation signals might be telling you. The stock is down about 5.2% over the past week and 1.0% over the past month, with returns also lower year to date at 8.7% and over the last year at 7.4%, even though the 3 year and 5 year returns sit at 26.4% and 108.4% respectively. Recent headlines around Formula One Group have kept attention on the long...
NYSE:RH
NYSE:RHSpecialty Retail

Is RH (RH) Worth Another Look After A 41% One Year Share Price Slide?

If you are wondering whether RH at US$123.17 is starting to look mispriced, the key question is what the current share price actually gives you in terms of underlying value. The stock has had a rough patch, with returns down 8.0% over the past week, 4.9% over the past month, 36.3% year to date and 41.4% over the last year, which can change how investors view both its potential and its risks. Recent attention on RH has focused on how the business is positioned within the higher end of the...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Alignment Healthcare’s Seventh PQA Award And The Medicare Advantage Story

Alignment Healthcare (NasdaqGS:ALHC) received its seventh PQA Excellence in Quality Award. The recognition reflects perfect scores on key Medicare Advantage prescription drug quality measures. The award highlights the company's ongoing focus on medication adherence and safety for seniors. Alignment Healthcare focuses on Medicare Advantage plans for seniors, with an emphasis on coordinated medical and pharmacy benefits. The latest PQA Excellence in Quality Award keeps attention on how the...
NYSE:FLS
NYSE:FLSMachinery

Is Flowserve (FLS) Offering A Reset Opportunity After Recent Share Price Pullback

If you are wondering whether Flowserve at around US$65.07 is offering good value today, the answer depends on how you look at its price tag versus its fundamentals. The stock has pulled back recently, with the share price down about 8.5% over the past week and 17.4% over the last month, although it still shows a 27.8% return over 1 year and 95.1% over 3 years. Recent headlines around the stock have focused on its role in capital goods and industrial equipment, as investors reassess how such...
NasdaqGM:ARDX
NasdaqGM:ARDXBiotechs

Ardelyx (ARDX) Is Down 8.1% After New Long-Term XPHOZAH Dialysis Data - Has The Bull Case Changed?

Earlier this month, Ardelyx announced new data from its NORMALIZE and OPTIMIZE trials showing that XPHOZAH (tenapanor) sustainably lowers serum phosphate in chronic kidney disease patients on dialysis without clinically meaningful changes in other serum electrolytes, nutrition markers, body mass, or blood pressure. The extended long-term safety and efficacy profile, combined with its first-in-class phosphate absorption inhibition mechanism, could further differentiate XPHOZAH as an add-on...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

F5’s Kubernetes-Native Security And AI Push With Red Hat Could Be A Game Changer For F5 (FFIV)

In May 2026, F5 announced new milestones in its collaboration with Red Hat, launching F5 WAF for NGINX on NGINX Gateway Fabric to bring enterprise-grade Layer 7 protection and security-as-code workflows to Kubernetes-native applications running on Red Hat OpenShift. F5 and Red Hat also introduced AI quickstarts for Red Hat OpenShift AI, offering pre-built chatbot and AI security blueprints to help organizations deploy and experiment with AI workloads more efficiently while addressing...
NYSE:MWA
NYSE:MWAMachinery

Record Quarter and Acquisition Push Could Be A Game Changer For Mueller Water Products (MWA)

In its recently reported fiscal second quarter, Mueller Water Products, Inc. posted record results, with net sales of US$384.4 million and net income of US$59.1 million, and reiterated full-year 2026 net sales guidance of US$1.47 billion to US$1.49 billion. Management highlighted a stronger balance sheet with US$585 million of liquidity and no debt maturities until June 2029, positioning the company to pursue disciplined acquisitions alongside ongoing capital investment and cash returns to...